SEC Form 4 · accession 0001596771-15-000029
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey M Rowe
Officer — EVP of Operations · Director
Period of report
Mar 25, 2015
Accepted (ET)
Mar 27, 2015 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 25, 2015 | S | 600,000 | $29.00 | D | 1,000,284 | D | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Daughter | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Son | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Son | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Daughter | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Son | |
| Common Stock | holding | — | — | — | 127,500 | I | Rowe Charitable Remainder Unitrust | |
| Common Stock | holding | — | — | — | 281,667 | I | Rowe Family Trusts |
Table II — derivative securities
No Table II lines on this filing.